Which has the lower trailing P/E, IQV or TEVA?

IQV has the lower trailing P/E: IQV trades at 32.55 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, IQV or TEVA?

Over the past five years, IQV grew revenue faster — IQV at a 5.61% CAGR versus TEVA at 1.19%.

Is IQV or TEVA more profitable?

IQV runs the higher net margin — IQV at 8.10% versus TEVA at 4.08%.

How have IQV and TEVA total returns compared?

Over the past 10 years, IQV delivered 13.24% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

IQVIA Holdings Inc. (IQV) vs Teva Pharmaceutical Industries Limited (TEVA)

A side-by-side comparison of IQVIA Holdings Inc. and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

IQV

IQVIA Holdings Inc.

$43.10B

$261.82HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

TEVA

Teva Pharmaceutical Industries Limited

$42.66B

$36.63HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

Total return — IQV vs TEVA

growth of $100 · dividends reinvested · last 10y

IQV +238.9% (+13.0%/yr)TEVA -23.4% (-2.6%/yr)IQV compounded faster over this window

IQV TEVA

IQV vs TEVA: by the numbers

•IQV is the larger company ($43.10B vs $42.66B market cap).
•IQV trades at the lower trailing earnings multiple (32.55 vs 62.70 P/E), one valuation lens rather than an overall verdict.
•IQV converts more revenue to profit (8.10% vs 4.08% net margin).
•IQV grew revenue faster over the past five years (5.61% vs 1.19% CAGR).

Metrics side by side

Valuation

Metric	IQV	TEVA
P/E ratio	32.55	62.70
Forward P/E	20.23	18.80
P/S ratio	2.60	2.57
P/B ratio	7.17	5.73
EV / EBITDA	16.79	19.40
FCF yield	5.91%	3.03%

Profitability

Metric	IQV	TEVA
Gross margin	26.23%	52.47%
Operating margin	13.57%	11.45%
Net margin	8.10%	4.08%
ROE	22.28%	9.10%
ROIC	8.32%	6.79%

Growth (annualized)

Metric	IQV	TEVA
Revenue CAGR (5Y)	5.61%	1.19%
EPS CAGR (5Y)	40.21%	N/A
FCF CAGR (5Y)	4.44%	14.58%
Total return CAGR (5Y)	0.22%	32.11%

Frequently asked

Which has the lower trailing P/E, IQV or TEVA?: IQV has the lower trailing P/E: IQV trades at 32.55 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, IQV or TEVA?: Over the past five years, IQV grew revenue faster — IQV at a 5.61% CAGR versus TEVA at 1.19%.
Is IQV or TEVA more profitable?: IQV runs the higher net margin — IQV at 8.10% versus TEVA at 4.08%.
How have IQV and TEVA total returns compared?: Over the past 10 years, IQV delivered 13.24% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IQV analysis Full TEVA analysis Interactive comparison tool

Dig into the metrics

IQVIA P/E ratio Teva Pharmaceutical Industries P/E ratio IQVIA ROE Teva Pharmaceutical Industries ROE IQVIA operating margin Teva Pharmaceutical Industries operating margin IQVIA revenue growth Teva Pharmaceutical Industries revenue growth IQVIA free cash flow Teva Pharmaceutical Industries free cash flow

IQVIA & Teva Pharmaceutical Industries appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.